View in EDS HTML Full Text PDF Full Text

Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.

Saved in:
Bibliographic Details
Title: Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.
Authors: Hatanaka, Takeshi1 (AUTHOR) hatanaka@qk9.so‐net.ne.jp, Kakizaki, Satoru2,3 (AUTHOR), Hiraoka, Atsushi4 (AUTHOR), Tada, Toshifumi5 (AUTHOR), Hirooka, Masashi6 (AUTHOR), Kariyama, Kazuya7 (AUTHOR), Tani, Joji8 (AUTHOR), Atsukawa, Masanori9 (AUTHOR), Takaguchi, Koichi10 (AUTHOR), Itobayashi, Ei11 (AUTHOR), Fukunishi, Shinya12 (AUTHOR), Tsuji, Kunihiko13 (AUTHOR), Ishikawa, Toru14 (AUTHOR), Tajiri, Kazuto15 (AUTHOR), Ochi, Hironori16 (AUTHOR), Yasuda, Satoshi17 (AUTHOR), Toyoda, Hidenori17 (AUTHOR), Ogawa, Chikara18 (AUTHOR), Nishimura, Takashi19 (AUTHOR), Shimada, Noritomo20 (AUTHOR)
Source: Cancer Medicine. Mar2023, Vol. 12 Issue 5, p5293-5303. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.5337